Selective stimulation of the subthalamic nucleus

D.G.M Zwartjes - de Klerk

    Research output: ThesisPhD Thesis - Research UT, graduation UT

    86 Downloads (Pure)

    Abstract

    Parkinson's disease (PD) is the second most common neurodegenerative disorder. In 2008, about 30.000 PD patients were registered at hospitals in the Netherlands. The number of PD patients is expected to increase by 47% from 2005 to 2025. PD is characterized by several motor related symptoms including tremor, bradykinesia, i.e. reduced movement speed and amplitude, hypokinesia, i.e. poverty of movement, episodes of freezing, impaired balance and postural control, dyskinesia, i.e. overactivity of muscles, rigidity, and adaptive responses. In the initial stage, PD is usually treated with Levodopa. This treatment is often very effective, but the efficacy of levodopa drops with time. The disease progressively becomes more severe and therefore it becomes increasingly difficult to treat in advanced stages. Surgical treatment in PD is usually employed when the patient responds well to medication, but experiences motor fluctuations and intolerable side effects as a result of high dosages.
    Original languageUndefined
    Awarding Institution
    • University of Twente
    Supervisors/Advisors
    • Veltink, Petrus H., Supervisor
    • Heida, Tjitske , Advisor
    Thesis sponsors
    Award date31 May 2013
    Place of PublicationEnschede
    Publisher
    Print ISBNs978-90-365-35304
    DOIs
    Publication statusPublished - 31 May 2013

    Keywords

    • IR-86133
    • EWI-23377
    • Subthalamic nucleus
    • METIS-296523
    • BSS-Electrical Neurostimulation
    • parkinson
    • selective stimulation
    • Deep Brain Stimulation

    Cite this

    Zwartjes - de Klerk, D. G. M. (2013). Selective stimulation of the subthalamic nucleus. Enschede: University of Twente. https://doi.org/10.3990/1.9789036535304
    Zwartjes - de Klerk, D.G.M. / Selective stimulation of the subthalamic nucleus. Enschede : University of Twente, 2013. 170 p.
    @phdthesis{a53fc3bbd3ba468b9a88920ccb46d570,
    title = "Selective stimulation of the subthalamic nucleus",
    abstract = "Parkinson's disease (PD) is the second most common neurodegenerative disorder. In 2008, about 30.000 PD patients were registered at hospitals in the Netherlands. The number of PD patients is expected to increase by 47{\%} from 2005 to 2025. PD is characterized by several motor related symptoms including tremor, bradykinesia, i.e. reduced movement speed and amplitude, hypokinesia, i.e. poverty of movement, episodes of freezing, impaired balance and postural control, dyskinesia, i.e. overactivity of muscles, rigidity, and adaptive responses. In the initial stage, PD is usually treated with Levodopa. This treatment is often very effective, but the efficacy of levodopa drops with time. The disease progressively becomes more severe and therefore it becomes increasingly difficult to treat in advanced stages. Surgical treatment in PD is usually employed when the patient responds well to medication, but experiences motor fluctuations and intolerable side effects as a result of high dosages.",
    keywords = "IR-86133, EWI-23377, Subthalamic nucleus, METIS-296523, BSS-Electrical Neurostimulation, parkinson, selective stimulation, Deep Brain Stimulation",
    author = "{Zwartjes - de Klerk}, D.G.M",
    year = "2013",
    month = "5",
    day = "31",
    doi = "10.3990/1.9789036535304",
    language = "Undefined",
    isbn = "978-90-365-35304",
    publisher = "University of Twente",
    address = "Netherlands",
    school = "University of Twente",

    }

    Zwartjes - de Klerk, DGM 2013, 'Selective stimulation of the subthalamic nucleus', University of Twente, Enschede. https://doi.org/10.3990/1.9789036535304

    Selective stimulation of the subthalamic nucleus. / Zwartjes - de Klerk, D.G.M.

    Enschede : University of Twente, 2013. 170 p.

    Research output: ThesisPhD Thesis - Research UT, graduation UT

    TY - THES

    T1 - Selective stimulation of the subthalamic nucleus

    AU - Zwartjes - de Klerk, D.G.M

    PY - 2013/5/31

    Y1 - 2013/5/31

    N2 - Parkinson's disease (PD) is the second most common neurodegenerative disorder. In 2008, about 30.000 PD patients were registered at hospitals in the Netherlands. The number of PD patients is expected to increase by 47% from 2005 to 2025. PD is characterized by several motor related symptoms including tremor, bradykinesia, i.e. reduced movement speed and amplitude, hypokinesia, i.e. poverty of movement, episodes of freezing, impaired balance and postural control, dyskinesia, i.e. overactivity of muscles, rigidity, and adaptive responses. In the initial stage, PD is usually treated with Levodopa. This treatment is often very effective, but the efficacy of levodopa drops with time. The disease progressively becomes more severe and therefore it becomes increasingly difficult to treat in advanced stages. Surgical treatment in PD is usually employed when the patient responds well to medication, but experiences motor fluctuations and intolerable side effects as a result of high dosages.

    AB - Parkinson's disease (PD) is the second most common neurodegenerative disorder. In 2008, about 30.000 PD patients were registered at hospitals in the Netherlands. The number of PD patients is expected to increase by 47% from 2005 to 2025. PD is characterized by several motor related symptoms including tremor, bradykinesia, i.e. reduced movement speed and amplitude, hypokinesia, i.e. poverty of movement, episodes of freezing, impaired balance and postural control, dyskinesia, i.e. overactivity of muscles, rigidity, and adaptive responses. In the initial stage, PD is usually treated with Levodopa. This treatment is often very effective, but the efficacy of levodopa drops with time. The disease progressively becomes more severe and therefore it becomes increasingly difficult to treat in advanced stages. Surgical treatment in PD is usually employed when the patient responds well to medication, but experiences motor fluctuations and intolerable side effects as a result of high dosages.

    KW - IR-86133

    KW - EWI-23377

    KW - Subthalamic nucleus

    KW - METIS-296523

    KW - BSS-Electrical Neurostimulation

    KW - parkinson

    KW - selective stimulation

    KW - Deep Brain Stimulation

    U2 - 10.3990/1.9789036535304

    DO - 10.3990/1.9789036535304

    M3 - PhD Thesis - Research UT, graduation UT

    SN - 978-90-365-35304

    PB - University of Twente

    CY - Enschede

    ER -

    Zwartjes - de Klerk DGM. Selective stimulation of the subthalamic nucleus. Enschede: University of Twente, 2013. 170 p. https://doi.org/10.3990/1.9789036535304